AUERBACH ALAN H 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Jan 8, 2026
Insider Transaction Report
Form 4
AUERBACH ALAN H
DirectorPresident and CEO10% Owner
Transactions
- Sale
Common Stock
2026-01-06$5.84/sh−16,938$98,986→ 7,163,963 total - Sale
Common Stock
2026-01-07$5.88/sh−18,012$105,893→ 7,145,951 total
Footnotes (1)
- [F1]Adoption date of referenced 10b5-1(c) plan is: 12-17-2020